omega-conotoxin-(conus-magus) and Substance-Withdrawal-Syndrome

omega-conotoxin-(conus-magus) has been researched along with Substance-Withdrawal-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for omega-conotoxin-(conus-magus) and Substance-Withdrawal-Syndrome

ArticleYear
Influence of omega-conotoxin on morphine analgesia and withdrawal syndrome in rats.
    European journal of pharmacology, 1992, Jul-21, Volume: 218, Issue:1

    The effect of omega-conotoxin on opiate analgesia and withdrawal syndrome was investigated in rats. omega-Conotoxin given i.c.v. and i.p. caused weak analgesia in the tail-flick test. When the toxin (20 ng/rat) was given i.c.v. immediately before morphine (1.5 micrograms/rat i.c.v.) the resultant analgesic effect was additive. In contrast, the analgesia elicited by morphine (3 micrograms/rat i.c.v.) was greatly reduced after 24-h pretreatment with the toxin (20 ng/rat i.c.v.). The systemic administration of the toxin (10 micrograms/kg i.p.) did not affect morphine analgesia whether omega-conotoxin was coadministered with morphine (2.5 mg/kg i.p.) or was given 24 h before the opiate (5 mg/kg i.p.). omega-Conotoxin i.c.v. injected in morphine-dependent rats 15 min before naloxone challenge significantly attenuated the abstinence syndrome. On the contrary systemic administration of omega-conotoxin failed to suppress the morphine withdrawal syndrome. The present results suggest that omega-conotoxin affects both acute and chronic effects of morphine.

    Topics: Analgesia; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Female; Mollusk Venoms; Morphine; Naloxone; omega-Conotoxins; Peptides, Cyclic; Rats; Substance Withdrawal Syndrome

1992